Skip to main content
Home / The International Journal of Tuberculosis and Lung Disease, Volume 20, Supplement 1

The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

Publisher: International Union Against Tuberculosis and Lung Disease

More about this publication?
Volume 20, Supplement 1, 1 December 2016

EDITORIAL

Open Access Optimizing MDR-TB clinical trials: insights from the first global MDR-TB Clinical Trials Landscape Meeting
pp. S1-S3(3)
Authors: Horsburgh, C. Robert; Rusen, I. D.; Mitnick, Carole D.

Favourites:
ADD

ORIGINAL ARTICLES

Open Access Methodological considerations in clinical trials for new MDR-TB treatment regimens
pp. S4-S7(4)
Author: Phillips, P. P. J.

Favourites:
ADD

Open Access Bayesian adaptive randomization in a clinical trial to identify new regimens for MDR-TB: the endTB trial
pp. S8-S12(5)
Authors: Cellamare, M.; Milstein, M.; Ventz, S.; Baudin, E.; Trippa, L.; Mitnick, C. D.

Favourites:
ADD

Open Access Methods for selecting regimen duration to prevent relapse in drug-susceptible and drug-resistant TB
pp. S13-S17(5)
Authors: Davies, G. R.; Wallis, R. S.

Favourites:
ADD

Open Access (Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis
pp. S18-S23(6)
Authors: Milstein, M.; Brzezinski, A.; Varaine, F.; Mitnick, C. D.

Favourites:
ADD

Open Access Selected questions and controversies about bedaquiline: a view from the field
pp. S24-S32(9)
Authors: Dheda, K.; Esmail, A.; Limberis, J.; Maartens, G.

Favourites:
ADD

Open Access Delamanid in the treatment of multidrug-resistant tuberculosis
pp. S33-S37(5)
Authors: Gupta, R.; Wells, C. D.; Hittel, N.; Hafkin, J.; Geiter, L. J.

Favourites:
ADD

Open Access TB Alliance regimen development for multidrug-resistant tuberculosis
pp. S38-S41(4)
Authors: Murray, S.; Mendel, C.; Spigelman, M.

Favourites:
ADD

Open Access Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis
pp. S42-S47(6)
Author: Sterling, T. R.

Favourites:
ADD

Open Access Evolving strategies for dose optimization of linezolid for treatment of tuberculosis
pp. S48-S51(4)
Author: Nuermberger, E.

Favourites:
ADD

Open Access Elucidating the role of clofazimine for the treatment of tuberculosis
pp. S52-S57(6)
Authors: O'Donnell, M. R.; Padayatchi, N.; Metcalfe, J. Z.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content